about
New insights into estrogenic regulation of O6-methylguanine DNA-methyltransferase (MGMT) in human breast cancer cells: Co-degradation of ER-α and MGMT proteins by fulvestrant or O6-benzylguanine indicates fresh avenues for therapy.Posttranslational Regulation of O(6)-Methylguanine-DNA Methyltransferase (MGMT) and New Opportunities for Treatment of Brain Cancers.Potent anti-proliferative actions of a non-diuretic glucosamine derivative of ethacrynic acid.Design and synthesis of a C7-aryl piperlongumine derivative with potent antimicrotubule and mutant p53-reactivating properties.The Process and Regulatory Components of Inflammation in Brain Oncogenesis.Brain- and brain tumor-penetrating disulfiram nanoparticles: Sequence of cytotoxic events and efficacy in human glioma cell lines and intracranial xenografts.Beyond Brooding on Oncometabolic Havoc in IDH-Mutant Gliomas and AML: Current and Future Therapeutic Strategies.S-phase Specific Downregulation of Human O6-Methylguanine DNA Methyltransferase (MGMT) and its Serendipitous Interactions with PCNA and p21cip1 Proteins in Glioma Cells.Conception, synthesis, and characterization of a rofecoxib-combretastatin hybrid drug with potent cyclooxygenase-2 (COX-2) inhibiting and microtubule disrupting activities in colon cancer cell culture and xenograft models.Cancer-Specific Biomarker hNQO1-Activatable Fluorescent Probe for Imaging Cancer Cells In Vitro and In VivoSelective killing of human breast cancer cells by the styryl lactone (R)-goniothalamin is mediated by glutathione conjugation, induction of oxidative stress and marked reactivation of the R175H mutant p53 proteinCharacterization of a highly specific NQO1-activated near-infrared fluorescent probe and its application for in vivo tumor imagingEXTH-36. DEVELOPMENT OF STABLE AND BRAIN-PENETRATING DISULFIRAM NANOPARTICLES, CHARACTERIZATION AND EFFICACY IN GLIOMA CELL CULTURE AND XENOGRAFT MODELS
P50
Q37300127-E5EB86FE-3913-4D1C-9FF1-32837B88D45FQ38552355-7E4B67C7-4E77-4E67-993C-25E2779C171FQ38772463-5BB5453C-27EC-4C30-A0DB-4C59FFE47EADQ38817299-7B59F649-E9BF-4A06-AA76-FACA5CACB9D3Q39202332-0EB555F0-1CC1-4363-A54B-47A29F1C0A1DQ49181990-DD8DB465-73D3-4D1A-B60C-3D254917FDD4Q50033966-F3C389C4-B2E9-4A10-83DD-1A6E57FB4FD4Q52728517-48EB519E-ACCC-4AFE-B6C4-17F7FFE357DCQ55190499-9EB16013-76F0-46BA-98DA-34A9356F6D94Q60931062-F29C8BB1-71F5-43F6-809C-538303837D56Q90238031-C98A62A9-13A8-4DA9-AF4B-DBE92EEED433Q92691089-23E6AC05-C76A-4D23-85C7-A6BB0C49CEF7Q94404030-16783A48-96E6-4583-B630-EF7BB8C0372F
P50
description
researcher ORCID ID = 0000-0001-8086-3188
@en
wetenschapper
@nl
name
Hanumantha Rao Madala
@ast
Hanumantha Rao Madala
@en
Hanumantha Rao Madala
@es
Hanumantha Rao Madala
@nl
type
label
Hanumantha Rao Madala
@ast
Hanumantha Rao Madala
@en
Hanumantha Rao Madala
@es
Hanumantha Rao Madala
@nl
prefLabel
Hanumantha Rao Madala
@ast
Hanumantha Rao Madala
@en
Hanumantha Rao Madala
@es
Hanumantha Rao Madala
@nl
P1153
56968034400
P31
P496
0000-0001-8086-3188